Federal Prime Contractor Profile
Large Enterprise Prime

MCKESSON CORPORATION

UEI:S1RUKWWRYFL6
CAGE:38157
Washington, TX 75039

MCKESSON CORPORATION is a federal contractor providing Computer Systems Design Services to departments including the Department of Defense.

Executive Summary
Verified SAM.gov & FPDS Data

Between 2018 and 2026, MCKESSON CORPORATION captured $9.50B across federal task orders and definitive prime awards, recording $3.33B in trailing 12-month obligations. Its primary federal customer is the Department of Defense (60% of total obligations), while maintaining an overall historical recompete retention rate of 87.6% with an average award cycle of 36 days.

Top Agency: Department of Defense (60% share)
Recompete Retention: 87.6%
Average Award Cycle: 36 Days
Primary Industry: NAICS 541512 (Computer Systems Design Services)
Active Task Orders: 9
Competition Profile: 3.1 avg bidders
Lifetime Federal Obligations
$9.50B
Cumulative prime contract awards
Trailing 12-Month Spend
$3.33B
Recent annualized award velocity
Recompete Retention Rate
87.6%
Historical recompete win rate
Average Award Cycle
36 Days
RFP release to definitive award
Prime vs. Sub Ratio
89% Prime
11% Subcontractor work
Average Bid Competition
3.1 Bidders
Average competing offers received

Agency Contracting Breakdown

Historical performance, award volumes, and recompete retention by federal agency.

Major Prime Contract Awards & Vehicles

Active definitive awards and delivery orders recorded in federal procurement databases.

Award PIID / VehicleAwarding AgencyCompetition TypePeriod of PerformanceObligated Amount
36C24025K1012
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER
Full and Open Competition
3 bidders
Sep 1, 2025
to Sep 30, 2025
$1.18B
Potential Value: $1.77B
36C24025K1010
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JULY
Full and Open Competition
4 bidders
Jul 1, 2025
to Jul 31, 2025
$1.12B
Potential Value: $1.68B
36C24025K1011
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 AUGUST
Full and Open Competition
3 bidders
Aug 1, 2025
to Aug 30, 2025
$1.08B
Potential Value: $1.61B
36C24025K1001
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 OCTOBER
Full and Open Competition
4 bidders
Oct 1, 2024
to Oct 31, 2024
$1.05B
Potential Value: $1.57B
36C24025K1007
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 APRIL
Full and Open Competition
4 bidders
Apr 1, 2025
to Apr 30, 2025
$1.05B
Potential Value: $1.57B
MCKESSON CORPORATION - Federal Contracting Profile & Analytics | GovMatrix